Korea FilingsFull brief — $39

SAMJIN PHARMACEUTICAL CO.,LTD

삼진제약(주) · KOSPI: 005500 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
삼진제약(주)
Market / ticker
KOSPI · 005500
Industry
Pharmaceuticals and medicinal chemicals
Established
1968-04-18
Fiscal year ends
December
Website
www.samjinpharm.co.kr
DART corp code
00128412
Latest revenue
₩309.1B (FY2025)

Items worth checking

No rule-based items found in the latest annual report or the last 12 months of filings. This is a limited automated check, not a clean bill of health.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩292.1B₩308.3B₩309.1B
Operating income₩20.5B₩31.6B₩26.8B
Net income₩18.9B₩39.2B₩24.2B
Total assets₩419.9B₩425.2B₩470.5B
Total liabilities₩154.5B₩163.5B₩180.1B
Total equity₩265.4B₩261.7B₩290.4B
Share capital₩13.9B₩13.9B₩13.9B

Separate statements · FY2025 operating margin 8.7% · liabilities to equity 62% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 58 (current)한울회계법인Unqualified
Term 57 (prior)한울회계법인Unqualified
Term 56 (two years prior)한울회계법인Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

DateFilingOriginal
2026-09-02Officer / major shareholder ownership reportDART
2026-09-02Large shareholding (5%+) reportDART
2026-08-25Officer / major shareholder ownership reportDART
2026-08-25Officer / major shareholder ownership reportDART
2026-08-25Officer / major shareholder ownership reportDART
2026-08-25Large shareholding (5%+) reportDART
2026-08-25Large shareholding (5%+) reportDART
2026-08-14Half-year report (2026.06)DART
2026-08-10Officer / major shareholder ownership reportDART
2026-08-10Officer / major shareholder ownership reportDART
2026-08-10Officer / major shareholder ownership reportDART
2026-08-10Large shareholding (5%+) reportDART
2026-08-10Change in shareholdings of largest shareholderDART
2026-07-30Officer / major shareholder ownership reportDART
2026-07-24Officer / major shareholder trading plan reportDART
2026-07-24Officer / major shareholder trading plan reportDART
2026-07-24Officer / major shareholder trading plan reportDART
2026-07-21Large shareholding (5%+) reportDART
2026-07-10Officer / major shareholder trading plan reportDART
2026-07-10Officer / major shareholder trading plan reportDART

Showing the 20 most recent of 51 filings. The full brief lists all of them.

Full brief on SAMJIN PHARMACEUTICAL CO.,LTD — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.